These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 11751141)
1. Gatifloxacin efficacy in treatment of experimental methicillin-sensitive Staphylococcus aureus-induced osteomyelitis in rabbits. Shirtliff ME; Calhoun JH; Mader JT Antimicrob Agents Chemother; 2002 Jan; 46(1):231-3. PubMed ID: 11751141 [TBL] [Abstract][Full Text] [Related]
2. Comparative evaluation of oral levofloxacin and parenteral nafcillin in the treatment of experimental methicillin-susceptible Staphylococcus aureus osteomyelitis in rabbits. Shirtliff ME; Calhoun JH; Mader JT J Antimicrob Chemother; 2001 Aug; 48(2):253-8. PubMed ID: 11481297 [TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of A-56619, A-56620, and nafcillin in the treatment of experimental Staphylococcus aureus osteomyelitis. Mader JT; Morrison LT; Adams KR Antimicrob Agents Chemother; 1987 Feb; 31(2):259-63. PubMed ID: 3566251 [TBL] [Abstract][Full Text] [Related]
4. Gatifloxacin biodegradable implant for treatment of experimental osteomyelitis: in vitro and in vivo evaluation. El-Kamel AH; Baddour MM Drug Deliv; 2007 Aug; 14(6):349-56. PubMed ID: 17701524 [TBL] [Abstract][Full Text] [Related]
5. Oral rifampin plus azithromycin or clarithromycin to treat osteomyelitis in rabbits. Shirtliff ME; Mader JT; Calhoun J Clin Orthop Relat Res; 1999 Feb; (359):229-36. PubMed ID: 10078148 [TBL] [Abstract][Full Text] [Related]
6. Clindamycin versus nafcillin or methicillin in the treatment of Staphylococcus aureus osteomyelitis in children. Kaplan SL; Mason EO; Feigin RD South Med J; 1982 Feb; 75(2):138-42. PubMed ID: 7036354 [TBL] [Abstract][Full Text] [Related]
7. Fluoroquinolone therapy in a rabbit model of post-LASIK methicillin-resistant Staphylococcus aureus keratitis. Balzli CL; McCormick CC; Caballero AR; Huang B; Wigington L; Smith E; Tang A; O'Callaghan RJ J Cataract Refract Surg; 2008 Feb; 34(2):295-301. PubMed ID: 18242457 [TBL] [Abstract][Full Text] [Related]
8. Fluoroquinolone therapy in multiple-drug resistant staphylococcal keratitis after lamellar keratectomy in a rabbit model. Tungsiripat T; Sarayba MA; Kaufman MB; Sweet PM; Taban M; Carpenter TR; McDonnell PJ Am J Ophthalmol; 2003 Jul; 136(1):76-81. PubMed ID: 12834673 [TBL] [Abstract][Full Text] [Related]
9. Comparison of minimal inhibitory and mutant prevention drug concentrations of 4 fluoroquinolones against clinical isolates of methicillin-susceptible and -resistant Staphylococcus aureus. Metzler K; Hansen GM; Hedlin P; Harding E; Drlica K; Blondeau JM Int J Antimicrob Agents; 2004 Aug; 24(2):161-7. PubMed ID: 15288315 [TBL] [Abstract][Full Text] [Related]
10. Teicoplanin versus nafcillin and vancomycin in the treatment of experimental endocarditis caused by methicillin-susceptible or -resistant Staphylococcus aureus. Chambers HF; Sande MA Antimicrob Agents Chemother; 1984 Jul; 26(1):61-4. PubMed ID: 6236747 [TBL] [Abstract][Full Text] [Related]
11. Comparative evaluation of tigecycline and vancomycin, with and without rifampicin, in the treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis in a rabbit model. Yin LY; Lazzarini L; Li F; Stevens CM; Calhoun JH J Antimicrob Chemother; 2005 Jun; 55(6):995-1002. PubMed ID: 15857944 [TBL] [Abstract][Full Text] [Related]
12. Microbiological tolerance in orthopaedic infections: delayed response of septic arthritis and osteomyelitis of the hip due to infection with tolerant Staphylococcus aureus. Thometz JG; Lamdan R; Kehl KS; Chusid MJ J Pediatr Orthop; 1996; 16(4):518-21. PubMed ID: 8784710 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of NEMO-binding domain peptide used to treat experimental osteomyelitis caused by methicillin-resistant Xu CP; Chen Y; Sun HT; Cui Z; Yang YJ; Huang L; Yu B; Wang FZ; Yang QP; Qi Y Antimicrob Resist Infect Control; 2019; 8():182. PubMed ID: 31832182 [TBL] [Abstract][Full Text] [Related]
14. Once-daily oral gatifloxacin versus oral levofloxacin in treatment of uncomplicated skin and soft tissue infections: double-blind, multicenter, randomized study. Tarshis GA; Miskin BM; Jones TM; Champlin J; Wingert KJ; Breen JD; Brown MJ Antimicrob Agents Chemother; 2001 Aug; 45(8):2358-62. PubMed ID: 11451697 [TBL] [Abstract][Full Text] [Related]
15. Ciprofloxacin therapy of experimental endocarditis caused by methicillin-susceptible or methicillin-resistant Staphylococcus aureus. Fernandez-Guerrero M; Rouse M; Henry N; Wilson W Antimicrob Agents Chemother; 1988 May; 32(5):747-51. PubMed ID: 3164989 [TBL] [Abstract][Full Text] [Related]
16. Effectiveness of nafcillin, methicillin, and cephalothin in experimental Staphylococcus aureus endocarditis. Carrizosa J; Kobasa WD; Kaye D Antimicrob Agents Chemother; 1979 May; 15(5):735-7. PubMed ID: 525991 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of besifloxacin in a rabbit model of methicillin-resistant Staphylococcus aureus keratitis. Sanders ME; Norcross EW; Moore QC; Shafiee A; Marquart ME Cornea; 2009 Oct; 28(9):1055-60. PubMed ID: 19724203 [TBL] [Abstract][Full Text] [Related]
18. Cefazolin versus Nafcillin for Methicillin-Sensitive Staphylococcus aureus Bloodstream Infection in a California Tertiary Medical Center. Pollett S; Baxi SM; Rutherford GW; Doernberg SB; Bacchetti P; Chambers HF Antimicrob Agents Chemother; 2016 Aug; 60(8):4684-9. PubMed ID: 27216053 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of besifloxacin in an early treatment model of methicillin-resistant Staphylococcus aureus keratitis. Sanders ME; Moore QC; Norcross EW; Shafiee A; Marquart ME J Ocul Pharmacol Ther; 2010 Apr; 26(2):193-8. PubMed ID: 20334537 [TBL] [Abstract][Full Text] [Related]